Abbott Laboratories ABT
NYSE ABT
$103.38 -1.86 (-1.76%)
As of: Sep 10, 2026 · 3:59 PM EDT

Abbott Laboratories (ABT) EBITDA Margin (QoQ) (2009 - 2026)

Analysis

Abbott Laboratories (ABT) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Zimmer Biomet Holdings 17.73 Bn 17.32 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 140.00
Mar 31, 2026 -760.00
Dec 31, 2025 155.00
Sep 30, 2025 -32.00
Jun 30, 2025 207.00
Mar 31, 2025 -107.00
Dec 31, 2024 -7.00
Sep 30, 2024 140.00
Jun 30, 2024 217.00
Mar 31, 2024 -347.00
Dec 31, 2023 114.00
Sep 30, 2023 78.00
Jun 30, 2023 -3.00
Mar 31, 2023 256.00
Dec 31, 2022 -408.00
Sep 30, 2022 -410.00
Jun 30, 2022 -337.00
Mar 31, 2022 374.00
Dec 31, 2021 -256.00
Sep 30, 2021 968.00